<DOC>
	<DOCNO>NCT01486186</DOCNO>
	<brief_summary>The purpose study evaluate effect safety Traditional Chinese medicine prevention management mild/moderate chronic obstructive pulmonary disease ( COPD ) .</brief_summary>
	<brief_title>Effect Traditional Chinese Medicine Outcomes Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>This multicenter , randomize , double-blind , placebo control study evaluate effect Traditional Chinese medicine ( TCM ) COPD subject . Following 14 day run-in period , approximately 504 subject randomly assign double-blind treatment 52 week . After 52 week treatment period , subject treatment arm follow-up 52 week . The primary measure efficacy frequency exacerbation spirometric value ( e.g . FEV1 ) . Secondary efficacy measure include Dyspnea ( MMRC ) , Quality life ( CAT , SF-36 ) , Exercise Capacity ( 6MWD ) . Safety assess collection adverse event . There total 5 study visit ( randomization , 13 , 26 , 39 52 week treatment ) . A follow-up contact collection effect adverse event conduct approximately 52 week follow last study visit .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>A confirmed diagnosis mild/moderate COPD . Age 40 80 year . Syndrome differentiation belong Syndrome lungqi deficiency , Syndrome deficiency pulmonosplenic qi , Syndrome insufficiency QI lung kidney . Without participation interventional trial previous one month . With informed consent sign . Pregnant breastfeed woman . Any psychiatric condition render patient unable understand nature , scope possible consequence study . Complicated severe heart failure ( class Ⅳ NYHA heart function ) unstable hemodynamics . Complicated bronchial asthma , bronchiectasis active tuberculosis； Complicated obliterative bronchiolitis diffuse pantothenic bronchiolitis， Complicated pneumothorax , pleural effusion pulmonary embolism . Complicated neuromuscular disorder affect respiration . Complicated tumor . Complicated serious hepatic renal disease . Long period bed rest . Use oral parenteral corticosteroid 1 month Visit 1 . With immunodeficiency . Participating trial allergic use medicine .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Pulmonary Disease , Chronic Obstructive</keyword>
	<keyword>Double-Blind Method</keyword>
	<keyword>Medicine , Chinese Traditional</keyword>
	<keyword>Humans</keyword>
	<keyword>Treatment Outcome</keyword>
</DOC>